Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Carlos L. Arteaga
Based on 94 articles published since 2009
(Why 94 articles?)
||||
Expertise Level
The expertise of Carlos L. Arteaga ranks in the
  • Top 0.025%
  • ... of 264,224 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 94 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Arteaga, C L   ·   Arteaga, Carlos L   ·   Arteaga, C   ·   Arteaga, Carlos
Work Locations
Details
Most likely:    Vanderbilt University   Contact    
2019
  • Departments of Medicine, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · UTSW Simmons Cancer Center, Dallas, TX, 75230, USA. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Departments of Biochemistry, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Vanderbilt Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, 37232-6307, TN, USA. · Departments of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Robert H Lurie Comprehensive Cancer Center, Chicago, 60611, IL, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, 02114, MA, USA. · Baylor University Medical Center, Texas Oncology, , US Oncology, Dallas, 75246, TX, USA. · Guardant Health, Redwood City, 94063, CA, USA. · Novartis Institutes for Biomedical Research, Cambridge, 02139, MA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, 07936, NJ, USA. · Departments of Medicine, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · UTSW Simmons Cancer Center, Dallas, TX, 75230, USA. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Pubmed 30914635
2018
  • Centre René Gauducheau, Institut de Cancérologie de L'Ouest, Saint Herblain, France. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. · Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, Canada. · Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medical Oncology Clinic, Institut Jules Bordet, Brussels, Belgium. · Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Oncology Center, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology (MCMCC), Warsaw, Poland. · Macerata Hospital, Macerata, Italy. · Department of Surgery, Taipei-Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan. · UCLA Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, USA. · Department of Surgery and Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Institute of Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Breast Cancer Research Program, Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Breast Cancer Department, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Department of Medicine, Vanderbilt University, Nashville, USA. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Medical Center, University Hospital Schleswig-Holstein, Kiel, Germany. · Novartis Pharma S.A.S., Paris, France. · Novartis Institutes for BioMedical Research, Cambridge, USA. · Novartis Pharmaceuticals Corporation, East Hanover, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 30241001
  • Texas Oncology-Baylor Charles A. Sammons Cancer Center and US Oncology Network, 3410 Worth Street, Suite 400, Dallas, TX, 75246, USA. · Masaryk Memorial Cancer Institute, Žlutý kopec 543/7, 656 53, Brno, Czech Republic. · Netherlands Cancer Institute and BOOG Study Center, IJsbaanpad 9, 1076 CV, Amsterdam, The Netherlands. · University of Padova and Istituto Oncologico Veneto, IRCCS, Via Gattamelata, 64, Padua, Italy. · Vanderbilt-Ingram Cancer Center, 1301 Medical Center Dr #1710, Nashville, TN, 37232, USA. · Edinburgh Cancer Centre, University of Edinburgh, Crewe Rd S, Edinburgh, EH4 2XR, UK. · Sarah Cannon Research Institute, Fort Myers, FL, 33916, USA. · University Hospital of Besançon, Jean-Minjoz University Hospital, 3 Boulevard Alexandre Fleming, 25000, Besançon, France. · Lillebaelt Hospital, Kabbeltoft 25, 7100, Vejle, Denmark. · Highlands Oncology Group, 3232 N Northhills Blvd, Fayetteville, AR, 72703, USA. · Arizona Oncology, US Oncology Network, 3700 W State Rte 89A, Sedona, AZ, 86336, USA. · Novartis Pharma AG, Fabrikstrasse 2, 4056, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, 07936, USA. · University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Pubmed 29164421
  • 1 Department of Radiology and Radiological Science, Vanderbilt University School of Medicine, 1161 21st Ave S, CCC-1121 MCN, Nashville, TN 37232-2675. · 2 Icahn School of Medicine at Mount Sinai, New York, NY. · 3 Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN. · 4 Center of Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN. · 5 Department of Physics and Astronomy, Vanderbilt University, Nashville, TN. · 6 Department of Biological Sciences, Vanderbilt University, Nashville, TN. · 7 Vanderbilt-Ingram Cancer Center, Nashville, TN. · Pubmed 29064750
2017
  • Departments of Medicine and Cancer Biology; Breast Cancer Program, Vanderbilt-Ingram Cancer Center; Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 28495849
  • Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain. · Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada. · Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Department of Oncology, Ospedale di Macerata, Macerata, Italy. · Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. · Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium. · Novartis Pharma SAS, Paris, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Syros Pharmaceuticals, Watertown, MA, USA. · Novartis Pharma AG, Basel, Switzerland. · Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. · Pubmed 28576675
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. · University of Virginia Health Sciences Center, Charlottesville, Virginia. · University of Alabama, Birmingham, Alabama. · Methodist Hospital Research Institute, Houston, Texas. · Pubmed 28270498
  • Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Radiology and Radiological Science, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Genentech, Inc., South San Francisco, California. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28011460
  • Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Massachusetts General Hospital (MGH), Boston, Massachusetts. · Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Weill Cornell Medical College, New York, New York. · Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts. · Pubmed 27126994
  • Department of Medicine and Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Nashville, TN; Department of Cancer Biology, Vanderbilt University, Nashville, TN; Symphogen, Ballerup, Denmark. · Pubmed 29059433
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Biochemistry, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Instituto Nacional de Enfermedades Neoplásicas, 15038 Lima, Perú. · Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, Universidad de Valencia, 46010 Valencia, Spain. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address: · Pubmed 28978427
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Vanderbilt Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Instituto Nacional de Enfermedades Neoplásicas, Surquillo 15038, Peru. · Department of Surgery, Emory University, Atlanta, GA 30322, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA. · Genoptix Medical Laboratories, Carlsbad, CA 92008, USA. · Foundation Medicine Inc., Cambridge, MA 02141, USA. · Department of Pathology, Albany Medical College, Albany, NY 12208, USA. · Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Pubmed 28794284
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Clinical Medicine, University of Naples Federico II, Naples, Italy. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · XenTech, Evry, France. · LTTA Center, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 28751448
  • Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital (MGH) and Harvard Medical School (HMS), Boston, MA 02114, USA. · Oncology Translational Medicine, Novartis Institute for Biomedical Research, Cambridge, MA 02139, USA. · Department of Medicine, MGH Cancer Center and HMS, Boston, MA 02129, USA. · Department of Pathology, MGH and HMS, Boston, MA 02114, USA. · Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27514, USA. · Department of Genetics, University of North Carolina, Chapel Hill, NC 27514, USA. · Division of Hematology Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA. · Department of Pathology, Microbiology, and Immunology, Vanderbilt-Ingram Cancer Center, Nashville, TN 37203, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Nashville, TN 37203, USA. · Departments of Medicine and Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, TN 37203, USA. · Department of Medicine, MGH Cancer Center and HMS, Boston, MA 02129, USA. · Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital (MGH) and Harvard Medical School (HMS), Boston, MA 02114, USA. · Pubmed 28539475
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. · Department of Biomedical Informatics, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 28396358
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Prometheus Laboratories, San Diego, California. · Foundation Medicine, Cambridge, Massachusetts. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Department of Gynecology, University of Ulm, Ulm, Germany. · Novartis Pharmaceuticals, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Pubmed 28381415
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Biochemistry, Vanderbilt University, Nashville, Tennessee. · Vanderbilt Center for Structural Biology, Vanderbilt University, Nashville, Tennessee. · Department of Chemistry, Vanderbilt University, Nashville, Tennessee. · Guardant Health, Redwood City, California. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Foundation Medicine, Cambridge, Massachusetts. · Puma Biotechnology, Inc., Los Angeles, California. · AstraZeneca Pharmaceuticals, Cambridge, United Kingdom. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 28274957
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Vanderbilt Institute of Chemical Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Pathology, University of Arizona, Tucson, Arizona. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Pathology, Microbiology and Immunology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC. · Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Department of Medicine, University of Arizona, Tucson, Arizona. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 28249908
2016
  • Departments of Medicine and Cancer Biology; Breast Cancer Program, Vanderbilt-Ingram, Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA. · Pubmed 27896521
  • Departments of Medicine and Cancer Biology; Breast Cancer Program, Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, Tennessee 37232; email: , · Pubmed 26473415
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.) · and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas · Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.) · and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel · the Sarah Cannon Research Institute (H.A.B., D.Y.) · Vanderbilt-Ingram Cancer Center (C.L.A.) · and Tennessee Oncology (D.Y.) - all in Nashville · National Cancer Center Singapore, Singapore (Y.-S.Y.) · Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.) · Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.) · Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.) · University Hospital of Besançon, Besançon (C.V.) · and Centre Léon Bérard, Lyon (T.B.) - all in France · Duke University Medical Center, Durham, NC (K.L.B.) · Dana-Farber Cancer Institute, Boston (E.P.W.) · University of Ulm, Ulm (W.J.) · Onkologische Praxis, Velbert (A.N.) · University of Tübingen, Tübingen (E.-M.G.) · and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany · Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.) · University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.) · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.) · Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.) · Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.) · Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.) · Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.) · Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.) · Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.) · Oslo University Hospital, Oslo (E.W.) · Virginia Cancer Specialists, Arlington (A.M.F.) · Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.) · Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.) · Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.) · and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
  • Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, 37203, USA. · Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. · Center for Complex Networks Research, Northeastern University, Boston, MA, 02115, USA. · Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. · Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, 37203, USA. · Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. · Pubmed 27771839
  • Department of Biology, Seragon Pharmaceuticals, San Diego, United States. · Department of Translational Oncology, Genentech, South San Francisco, United States. · Department of Oncology Biomarker Development, Genentech, South San Francisco, United States. · Department of Biochemical and Cellular Pharmacology, Genentech, South San Francisco, United States. · Departments of Discovery Oncology and Early Discovery Biochemistry, Genentech, South San Francisco, United States. · Department of Chemistry, Seragon Pharmaceuticals, San Diego, United States. · Department of Drug Safety and Disposition, Seragon Pharmaceuticals, San Diego, United States. · Department of Molecular Biology, Genentech, South San Francisco, United States. · Department of Pathology, Genentech, South San Francisco, United States. · Department of Medicine and Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, United States. · Vanderbilt University Institute of Imaging Science, Vanderbilt University, Nashville, United States. · Pubmed 27410477
  • Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA. Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN 37232, USA. · Houston Methodist Cancer Center, Houston, TX 77030, USA. · Foundation Medicine, Cambridge, MA 02142, USA. · Departments of Pathology and Medicine, Yale University, New Haven, CT 06520, USA. · Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA. · Oncosalud, Lima 41, Perú. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima 34, Perú. · Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Pubmed 27075627
  • Breast Cancer Program, Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Pubmed 26979397
  • Department of Biomedical Engineering, Vanderbilt University, Station B, Box 1631, Nashville, Tennessee, 37235, USA. · Department of Cancer Biology, Vanderbilt University, 2220 Pierce Avenue, Nashville, Tennessee, USA. · Breast Cancer Research Program, Vanderbilt- Ingram Cancer Center, Vanderbilt University. · Department of Pathology, Microbiology &Immunology, Vanderbilt University Medical Center, 1301 Medical Center Drive 4918-A TVC Building, Nashville, Tennessee, 37232 USA. · Department of Medicine, Vanderbilt University, 2220 Pierce Avenue, Nashville, Tennessee, USA. · Pubmed 26738962
  • Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. · Cell Imaging Shared Resource, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Pubmed 26676751
  • Cancer Institute, The Second Hospital of Dalian Medical University, Dalian, China. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Biochemistry, Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA. · Pubmed 26640141
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, Department of Pathology, GZA Antwerp, Belgium. · Charité University and German Cancer Consortium (DKTK), Berlin, Germany. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Foundation Medicine, Cambridge, Massachusetts. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Maine Medical Center Research Institute, Scarborough, Maine. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Pubmed 26515496
2015
  • Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute · Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA · Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN · Carla I. Falkson, University of Alabama, Birmingham, AL · Timothy J. Hobday, Mayo Clinic, Rochester, MN · E. Claire Dees, University of North Carolina, Chapel Hill, NC · Rita Nanda, University of Chicago, Chicago, IL · Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX · and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. · Pubmed 26169615
  • Department of Medicine, Vanderbilt University, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Medicine, Vanderbilt University, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Cancer Biology, Vanderbilt University, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Cancer Biology, Vanderbilt University, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Pubmed 26637440
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Belfer Institute of Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Medicine, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA. · Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea. · Broad Institute, Cambridge, Massachusetts, USA. · Harvard Stem Cell Institute, Cambridge, Massachusetts, USA. · Pubmed 26301495
  • From the Departments of ‡Medicine. · §Biochemistry, ‡‡Jim Ayers Institute for Precancer Detection and Diagnosis, Vanderbilt University School of Medicine, Nashville, Tennessee; · ¶Cancer Biology. · ¶¶Departments of Pathology and Laboratory Medicine and Genetics; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; · ‡‡Jim Ayers Institute for Precancer Detection and Diagnosis, Vanderbilt University School of Medicine, Nashville, Tennessee; · §§Houston Methodist Cancer Center, Houston, Texas; · ‖Pathology, Microbiology and Immunology; **Breast Cancer Research Program; Vanderbilt Ingram Cancer Center, Nashville, Tennessee; · Baylor Charles A. Sammons Cancer Center, Dallas, Texas; · Foundation Medicine, Cambridge, Massachusetts. · ¶Cancer Biology, ‖Pathology, Microbiology and Immunology; · Baylor Charles A. Sammons Cancer Center, Dallas, Texas; Texas Oncology, US Oncology, Dallas, Texas; · ‖‖The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; · ¶Cancer Biology, **Breast Cancer Research Program; Vanderbilt Ingram Cancer Center, Nashville, Tennessee; · From the Departments of ‡Medicine, ¶Cancer Biology, **Breast Cancer Research Program; Vanderbilt Ingram Cancer Center, Nashville, Tennessee; · Pubmed 25953087
  • Vanderbilt University, Department of Biomedical Engineering Station B, Box 1631, Nashville, Tennessee 37235, United States. · Vanderbilt University, Department of Cancer Biology, Breast Cancer Research Program, 2220 Pierce Avenue, Nashville, Tennessee 37232, United States. · Vanderbilt University, Department of Cancer Biology, Breast Cancer Research Program, 2220 Pierce Avenue, Nashville, Tennessee 37232, United StatescVanderbilt University, Department of Medicine, 2220 Pierce Avenue, Nashville, Tennessee 37232, United States. · Pubmed 25700233
  • Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Medical Oncology, Broad Institute of MIT at Harvard, Cambridge, Massachusetts. · Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 25480943
  • Department of Life Science, Hanyang University, Seoul, Korea. · Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · The Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang-si, Korea. · NOVA Cell Technology Inc., Pohang, Korea. · Department of Medicine, Vanderbilt University, Nashville, TN, USA. · 1] Department of Life Science, Hanyang University, Seoul, Korea [2] Natural Science Institute, Hanyang University, Seoul, Korea. · Pubmed 25342465
  • Department of Pharmacology and Toxicology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. · 1] Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA [2] Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Proteomics Laboratory, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · 1] Department of Breast Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA [2] Department of Systems Biology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. · Department of Systems Biology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. · 1] Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA [2] Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA [3] Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · 1] Department of Pharmacology and Toxicology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA [2] Comprehensive Breast Cancer Program, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Pubmed 25284585
2014
  • Ingrid A. Mayer, Vandana G. Abramson, Justin M. Balko, María Gabriela Kuba, Melinda E. Sanders, and Carlos L. Arteaga, Vanderbilt University, Nashville, TN · Steven J. Isakoff, Massachusetts General Hospital, Boston, MA · Andres Forero, University of Alabama, Birmingham, AL · Jeffrey T. Yap, Huntsman Cancer Institute, Salt Lake City, UT · Annick D. Van den Abbeele and Eric Winer, Dana-Farber Cancer Institute, Boston, MA · Yisheng Li, MD Anderson Cancer Center, Houston, TX · and Lewis C. Cantley, Weill Cornell Medical College, New York, NY. · Pubmed 24663045
  • Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Division de Investigación, Oncosalud, Lima, Peru. · Center for Molecular Diagnostics, Lima, Peru. · Department of Pathology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Department of Medicine, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University, Nashville, TN, USA. · Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. Electronic address: · Pubmed 25467032
  • Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee. · Takis Biotech, Rome, Italy. · IRCCS National Cancer Institute "G. Pascale," Naples, Italy. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee. · Pubmed 25100563
  • Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX. · Bioinformatics and Computational Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX. · Department of Pharmacology and Toxicology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH. Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN. · University of Georgia College of Pharmacy, Athens, GA. · Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX. · Veterinary Medicine and Surgery, The University of Texas, MD Anderson Cancer Center, Houston, TX. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN. Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN. · Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX. · Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX. Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX. · Pubmed 24979294
  • Department of Medicine, Department of Cancer Biology, and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Medicine, Department of Cancer Biology, and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA · Pubmed 24797823
  • Vanderbilt University, Department of Biomedical Engineering, VU Station B #351631, 2301 Vanderbilt Place, Nashville, Tennessee 37235bUniversity of Texas Health Science Center at Houston, Department of Nanomedicine and Biomedical Engineering, CABIR 3SCR.46. · Vanderbilt University, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232. · Vanderbilt University, Vanderbilt Center for Quantitative Sciences, Nashville, Tennessee 37232. · Vanderbilt University, Department of Biomedical Engineering, VU Station B #351631, 2301 Vanderbilt Place, Nashville, Tennessee 37235. · Pubmed 24496495
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, 450 Brookline Ave. Boston, MA 02215. · Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215. · Foundation Medicine, One Kendall Sq. Cambridge, MA 02139. · Departments of Investigational Cancer Therapeutics, Surgical Oncology, The University of MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. · Departments of Systems Biology, and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. · Fundacion de Investigacion INCLIVA - Institute for Health Reseearch, Valencia, Spain. · Departments of Hematology-Oncology, Hospital Clinico Universitario de Valencia, Valencia, Spain. · Jefferson Breast Care Center, Kimmel Cancer Center, Thomas Jefferson University, 925 Chestnut St. Philadelphia, PA 19107. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2220 Pierce Ave, Nashville, TN 37232. · Teva Pharmaceuticals, 5 Basel St. Petach Tikva, Israel 49131. · Oncology Division, Tel Aviv Sourasky Medical Center , 6 Weizmann St. Tel Aviv 64239, Israel. · Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave. Boston MA 02215. · Breast Medical Oncology Program, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave. Boston MA 02215. · Section of Breast Medical Oncology, Yale School of Medicine, New Haven, South Frontage Rd and Park St. CN, 06510. · Pubmed 24398047
2013
  • Author's Affiliation: Departments of Medicine and Cancer Biology; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 24298065
2011
  • Breast Cancer Research Program, Vanderbilt Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, 1310 24th Avenue South, Nashville, TN 37212-2637, USA. · Pubmed 22124364
  • Departments of Medicine and Cancer Biology, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232-6307, USA. · Pubmed 21670086
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Division of Hematology/Oncology, VUMC, 2220 Pierce Avenue, 777 PRB, Nashville, TN 37232-6307, USA. · Pubmed 21457523
2015
  • Institute of Imaging Science, Vanderbilt University, 1161 21st Ave. South, MCN AA-1105, Nashville, TN, 37232-2675, USA. · Pubmed 25034624
2014
  • Department of Medicine, Vanderbilt University School of Medicine, 2220 Pierce Ave, 777 PRB, Nashville, TN, 37232, USA, · Pubmed 24722917
  • Departments of 1Medicine, 2Pathology, Microbiology & Immunology, 3Cancer Biology, and 4Biochemistry; 5Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee; Departments of 6Cell & Tissue Biology and 7Medicine, University of California, San Francisco, San Francisco, California; 8Foundation Medicine, Cambridge, Massachusetts; 9Oncosalud; and 10Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú · Pubmed 24356096
2013
  • Department of Medicine, Cancer Biology and Biostatistics, Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA. · Pubmed 23794708
  • Authors' Affiliations: Departments of Biomedical Engineering, Cancer Biology, Medicine, Vanderbilt University Institute of Imaging Science, and Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Nashville, Tennessee. · Pubmed 24130112
  • Authors' Affiliations: Departments of Medicine and Cancer Biology; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee; Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú; and Department of Pharmacology and Toxicology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. · Pubmed 23966295
  • Authors' Affiliations: Departments of Medicine and Cancer Biology, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center; Vanderbilt University, Nashville, Tennessee; Massachusetts General Hospital Cancer Center; and Department of Medicine, Harvard Medical School, Boston, Massachusetts. · Pubmed 23948973
  • Authors' Affiliations: Novartis Institutes for Biomedical Research, Cambridge, Massachusetts; Departments of Medicine and Cancer Biology; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee; MorphoSys AG, Martinsried, Germany; and Genomics Institute of the Novartis Research Foundation, San Diego, California. · Pubmed 23928993
  • Authors' Affiliations: Departments of Medicine and Cancer Biology; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center; Vanderbilt University, Nashville, Tennessee; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts; Integrated Oncology/LabCorp; and Monogram Biosciences/LabCorp, South San Francisco, California. · Pubmed 23918797
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 23391723
  • Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Pubmed 23224399
2012
  • Departments of Medicine and Cancer Biology, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37212, USA. · Pubmed 22471661
  • Vanderbilt University Medical Center, 2200 Pierce Ave, 777 PRB, Nashville, TN 37232-6307, USA. · Pubmed 22879364
  • Department of Medicine, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 22683778
  • Jim Ayers Institute for Precancer Detection and Diagnosis, Vanderbilt-Ingram Cancer Center, and Departments of ‡Biochemistry, §Pathology, and ¶Medicine, Vanderbilt University School of Medicine , Nashville, Tennessee 37232, United States. · Pubmed 22530795
  • Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Pubmed 22461506
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Pubmed 21368164
2011
  • Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Pubmed 22114931
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA. · Pubmed 22010023
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6307, USA. · Pubmed 21248299
  • Department of Cancer Biology, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee 37232-6307, USA. · Pubmed 22049316
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 21908557
  • Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. · Pubmed 21499296
  • Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Pubmed 21482676
  • Department of Medicine, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, and Vanderbilt University Institute of Imaging Sciences, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Pubmed 21385943
  • Department of Cancer Biology, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 21346144
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee 37232, USA. · Pubmed 21324925
Probable:    University of Texas Southwestern   Contact    
2019
  • Departments of Medicine, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · UTSW Simmons Cancer Center, Dallas, TX, 75230, USA. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Departments of Biochemistry, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Vanderbilt Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, 37232-6307, TN, USA. · Departments of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Robert H Lurie Comprehensive Cancer Center, Chicago, 60611, IL, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, 02114, MA, USA. · Baylor University Medical Center, Texas Oncology, , US Oncology, Dallas, 75246, TX, USA. · Guardant Health, Redwood City, 94063, CA, USA. · Novartis Institutes for Biomedical Research, Cambridge, 02139, MA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, 07936, NJ, USA. · Departments of Medicine, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · UTSW Simmons Cancer Center, Dallas, TX, 75230, USA. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Pubmed 30914635
2018
  • Department of Gynaecology and Obstetrics, University Hospitals Leuven, KU Leuven, University of Leuven, Herestraat 49, 3000, Louvain, Belgium. · Department of Oncology, University Hospitals Leuven, KU Leuven, University of Leuven, 3000, Louvain, Belgium. · Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, University of Leuven, 3000, Louvain, Belgium. · Department of Radiology, KU Leuven, University Hospitals Leuven, 3000, Louvain, Belgium. · Department of Pathology, KU Leuven, University Hospitals Leuven, 3000, Louvain, Belgium. · Department of Human Genetics, University Hospitals Leuven, KU Leuven, University of Leuven, 3000, Louvain, Belgium. · Department of Gynaecology and Obstetrics, University Hospitals Leuven, KU Leuven, University of Leuven, Herestraat 49, 3000, Louvain, Belgium. · Department of Radiotherapy, University Hospitals Leuven, KU Leuven, University of Leuven, 3000, Louvain, Belgium. · Department of Imaging and Pathology, Laboratory of Translational Cell and Tissue Research, KU Leuven, University of Leuven, 3000, Louvain, Belgium. · University of Texas Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, TX, USA. · Pubmed 30187361
  • Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York, 14263, USA. · Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, New York, USA. · Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York, USA. · Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. · Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York, 14263, USA. · Pubmed 29921235
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 94 total) written by Carlos L. Arteaga about Breast Neoplasms:

  • Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer. 2019
  • Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2. 2018
  • Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial. 2018
  • The Attenuation Distribution Across the Long Axis of Breast Cancer Liver Metastases at CT: A Quantitative Biomarker for Predicting Overall Survival. 2018
  • Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer. 2018
  • TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association. 2018
  • Neoadjuvant Trials in ER 2017
  • Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial. 2017
  • A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67. 2017
  • (no title) 2017
Show List of Full Article Records
Google Searches

Learn more about Carlos L. Arteaga using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Vanderbilt University
University of Texas Southwestern
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Vanderbilt University
2019
  • Departments of Medicine, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · UTSW Simmons Cancer Center, Dallas, TX, 75230, USA. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Departments of Biochemistry, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Vanderbilt Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, 37232-6307, TN, USA. · Departments of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Robert H Lurie Comprehensive Cancer Center, Chicago, 60611, IL, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, 02114, MA, USA. · Baylor University Medical Center, Texas Oncology, , US Oncology, Dallas, 75246, TX, USA. · Guardant Health, Redwood City, 94063, CA, USA. · Novartis Institutes for Biomedical Research, Cambridge, 02139, MA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, 07936, NJ, USA. · Departments of Medicine, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · UTSW Simmons Cancer Center, Dallas, TX, 75230, USA. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Pubmed 30914635
2018
  • Centre René Gauducheau, Institut de Cancérologie de L'Ouest, Saint Herblain, France. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. · Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, Canada. · Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medical Oncology Clinic, Institut Jules Bordet, Brussels, Belgium. · Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Oncology Center, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology (MCMCC), Warsaw, Poland. · Macerata Hospital, Macerata, Italy. · Department of Surgery, Taipei-Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan. · UCLA Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, USA. · Department of Surgery and Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Institute of Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Breast Cancer Research Program, Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Breast Cancer Department, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy. · Vanderbilt-Ingram Cancer Center, Department of Medicine, Vanderbilt University, Nashville, USA. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Medical Center, University Hospital Schleswig-Holstein, Kiel, Germany. · Novartis Pharma S.A.S., Paris, France. · Novartis Institutes for BioMedical Research, Cambridge, USA. · Novartis Pharmaceuticals Corporation, East Hanover, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 30241001
  • Texas Oncology-Baylor Charles A. Sammons Cancer Center and US Oncology Network, 3410 Worth Street, Suite 400, Dallas, TX, 75246, USA. · Masaryk Memorial Cancer Institute, Žlutý kopec 543/7, 656 53, Brno, Czech Republic. · Netherlands Cancer Institute and BOOG Study Center, IJsbaanpad 9, 1076 CV, Amsterdam, The Netherlands. · University of Padova and Istituto Oncologico Veneto, IRCCS, Via Gattamelata, 64, Padua, Italy. · Vanderbilt-Ingram Cancer Center, 1301 Medical Center Dr #1710, Nashville, TN, 37232, USA. · Edinburgh Cancer Centre, University of Edinburgh, Crewe Rd S, Edinburgh, EH4 2XR, UK. · Sarah Cannon Research Institute, Fort Myers, FL, 33916, USA. · University Hospital of Besançon, Jean-Minjoz University Hospital, 3 Boulevard Alexandre Fleming, 25000, Besançon, France. · Lillebaelt Hospital, Kabbeltoft 25, 7100, Vejle, Denmark. · Highlands Oncology Group, 3232 N Northhills Blvd, Fayetteville, AR, 72703, USA. · Arizona Oncology, US Oncology Network, 3700 W State Rte 89A, Sedona, AZ, 86336, USA. · Novartis Pharma AG, Fabrikstrasse 2, 4056, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover, NJ, 07936, USA. · University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Pubmed 29164421
  • 1 Department of Radiology and Radiological Science, Vanderbilt University School of Medicine, 1161 21st Ave S, CCC-1121 MCN, Nashville, TN 37232-2675. · 2 Icahn School of Medicine at Mount Sinai, New York, NY. · 3 Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN. · 4 Center of Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN. · 5 Department of Physics and Astronomy, Vanderbilt University, Nashville, TN. · 6 Department of Biological Sciences, Vanderbilt University, Nashville, TN. · 7 Vanderbilt-Ingram Cancer Center, Nashville, TN. · Pubmed 29064750
2017
  • Departments of Medicine and Cancer Biology; Breast Cancer Program, Vanderbilt-Ingram Cancer Center; Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 28495849
  • Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain. · Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada. · Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Department of Oncology, Ospedale di Macerata, Macerata, Italy. · Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. · Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium. · Novartis Pharma SAS, Paris, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Syros Pharmaceuticals, Watertown, MA, USA. · Novartis Pharma AG, Basel, Switzerland. · Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. · Pubmed 28576675
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. · University of Virginia Health Sciences Center, Charlottesville, Virginia. · University of Alabama, Birmingham, Alabama. · Methodist Hospital Research Institute, Houston, Texas. · Pubmed 28270498
  • Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Radiology and Radiological Science, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Genentech, Inc., South San Francisco, California. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28011460
  • Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Massachusetts General Hospital (MGH), Boston, Massachusetts. · Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Weill Cornell Medical College, New York, New York. · Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts. · Pubmed 27126994
  • Department of Medicine and Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Nashville, TN; Department of Cancer Biology, Vanderbilt University, Nashville, TN; Symphogen, Ballerup, Denmark. · Pubmed 29059433
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Biochemistry, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Instituto Nacional de Enfermedades Neoplásicas, 15038 Lima, Perú. · Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, Universidad de Valencia, 46010 Valencia, Spain. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address: · Pubmed 28978427
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Vanderbilt Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Instituto Nacional de Enfermedades Neoplásicas, Surquillo 15038, Peru. · Department of Surgery, Emory University, Atlanta, GA 30322, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA. · Genoptix Medical Laboratories, Carlsbad, CA 92008, USA. · Foundation Medicine Inc., Cambridge, MA 02141, USA. · Department of Pathology, Albany Medical College, Albany, NY 12208, USA. · Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Pubmed 28794284
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Clinical Medicine, University of Naples Federico II, Naples, Italy. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. · XenTech, Evry, France. · LTTA Center, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy. · Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 28751448
  • Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital (MGH) and Harvard Medical School (HMS), Boston, MA 02114, USA. · Oncology Translational Medicine, Novartis Institute for Biomedical Research, Cambridge, MA 02139, USA. · Department of Medicine, MGH Cancer Center and HMS, Boston, MA 02129, USA. · Department of Pathology, MGH and HMS, Boston, MA 02114, USA. · Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27514, USA. · Department of Genetics, University of North Carolina, Chapel Hill, NC 27514, USA. · Division of Hematology Oncology, Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA. · Department of Pathology, Microbiology, and Immunology, Vanderbilt-Ingram Cancer Center, Nashville, TN 37203, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Nashville, TN 37203, USA. · Departments of Medicine and Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, TN 37203, USA. · Department of Medicine, MGH Cancer Center and HMS, Boston, MA 02129, USA. · Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital (MGH) and Harvard Medical School (HMS), Boston, MA 02114, USA. · Pubmed 28539475
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. · Department of Biomedical Informatics, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 28396358
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Prometheus Laboratories, San Diego, California. · Foundation Medicine, Cambridge, Massachusetts. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, North Carolina. · Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. · Department of Gynecology, University of Ulm, Ulm, Germany. · Novartis Pharmaceuticals, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Pubmed 28381415
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Biochemistry, Vanderbilt University, Nashville, Tennessee. · Vanderbilt Center for Structural Biology, Vanderbilt University, Nashville, Tennessee. · Department of Chemistry, Vanderbilt University, Nashville, Tennessee. · Guardant Health, Redwood City, California. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Foundation Medicine, Cambridge, Massachusetts. · Puma Biotechnology, Inc., Los Angeles, California. · AstraZeneca Pharmaceuticals, Cambridge, United Kingdom. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 28274957
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Vanderbilt Institute of Chemical Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Pathology, University of Arizona, Tucson, Arizona. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Pathology, Microbiology and Immunology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC. · Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. · Department of Medicine, University of Arizona, Tucson, Arizona. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Pubmed 28249908
2016
  • Departments of Medicine and Cancer Biology; Breast Cancer Program, Vanderbilt-Ingram, Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA. · Pubmed 27896521
  • Departments of Medicine and Cancer Biology; Breast Cancer Program, Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, Tennessee 37232; email: , · Pubmed 26473415
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.) · and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas · Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.) · and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel · the Sarah Cannon Research Institute (H.A.B., D.Y.) · Vanderbilt-Ingram Cancer Center (C.L.A.) · and Tennessee Oncology (D.Y.) - all in Nashville · National Cancer Center Singapore, Singapore (Y.-S.Y.) · Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.) · Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.) · Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.) · University Hospital of Besançon, Besançon (C.V.) · and Centre Léon Bérard, Lyon (T.B.) - all in France · Duke University Medical Center, Durham, NC (K.L.B.) · Dana-Farber Cancer Institute, Boston (E.P.W.) · University of Ulm, Ulm (W.J.) · Onkologische Praxis, Velbert (A.N.) · University of Tübingen, Tübingen (E.-M.G.) · and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany · Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.) · University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.) · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.) · Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.) · Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.) · Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.) · Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.) · Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.) · Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.) · Oslo University Hospital, Oslo (E.W.) · Virginia Cancer Specialists, Arlington (A.M.F.) · Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.) · Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.) · Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.) · and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
  • Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, 37203, USA. · Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. · Center for Complex Networks Research, Northeastern University, Boston, MA, 02115, USA. · Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. · Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, 37203, USA. · Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. · Pubmed 27771839
  • Department of Biology, Seragon Pharmaceuticals, San Diego, United States. · Department of Translational Oncology, Genentech, South San Francisco, United States. · Department of Oncology Biomarker Development, Genentech, South San Francisco, United States. · Department of Biochemical and Cellular Pharmacology, Genentech, South San Francisco, United States. · Departments of Discovery Oncology and Early Discovery Biochemistry, Genentech, South San Francisco, United States. · Department of Chemistry, Seragon Pharmaceuticals, San Diego, United States. · Department of Drug Safety and Disposition, Seragon Pharmaceuticals, San Diego, United States. · Department of Molecular Biology, Genentech, South San Francisco, United States. · Department of Pathology, Genentech, South San Francisco, United States. · Department of Medicine and Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, United States. · Vanderbilt University Institute of Imaging Science, Vanderbilt University, Nashville, United States. · Pubmed 27410477
  • Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA. Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN 37232, USA. · Houston Methodist Cancer Center, Houston, TX 77030, USA. · Foundation Medicine, Cambridge, MA 02142, USA. · Departments of Pathology and Medicine, Yale University, New Haven, CT 06520, USA. · Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA. · Oncosalud, Lima 41, Perú. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima 34, Perú. · Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Pubmed 27075627
  • Breast Cancer Program, Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Pubmed 26979397
  • Department of Biomedical Engineering, Vanderbilt University, Station B, Box 1631, Nashville, Tennessee, 37235, USA. · Department of Cancer Biology, Vanderbilt University, 2220 Pierce Avenue, Nashville, Tennessee, USA. · Breast Cancer Research Program, Vanderbilt- Ingram Cancer Center, Vanderbilt University. · Department of Pathology, Microbiology &Immunology, Vanderbilt University Medical Center, 1301 Medical Center Drive 4918-A TVC Building, Nashville, Tennessee, 37232 USA. · Department of Medicine, Vanderbilt University, 2220 Pierce Avenue, Nashville, Tennessee, USA. · Pubmed 26738962
  • Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. · Cell Imaging Shared Resource, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Pubmed 26676751
  • Cancer Institute, The Second Hospital of Dalian Medical University, Dalian, China. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Biochemistry, Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA. · Pubmed 26640141
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, Department of Pathology, GZA Antwerp, Belgium. · Charité University and German Cancer Consortium (DKTK), Berlin, Germany. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Foundation Medicine, Cambridge, Massachusetts. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Maine Medical Center Research Institute, Scarborough, Maine. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Pubmed 26515496
2015
  • Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute · Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA · Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN · Carla I. Falkson, University of Alabama, Birmingham, AL · Timothy J. Hobday, Mayo Clinic, Rochester, MN · E. Claire Dees, University of North Carolina, Chapel Hill, NC · Rita Nanda, University of Chicago, Chicago, IL · Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX · and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. · Pubmed 26169615
  • Department of Medicine, Vanderbilt University, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Medicine, Vanderbilt University, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Cancer Biology, Vanderbilt University, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Cancer Biology, Vanderbilt University, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Department of Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN, 37232, USA. · Pubmed 26637440
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Belfer Institute of Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Medicine, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA. · Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea. · Broad Institute, Cambridge, Massachusetts, USA. · Harvard Stem Cell Institute, Cambridge, Massachusetts, USA. · Pubmed 26301495
  • From the Departments of ‡Medicine. · §Biochemistry, ‡‡Jim Ayers Institute for Precancer Detection and Diagnosis, Vanderbilt University School of Medicine, Nashville, Tennessee; · ¶Cancer Biology. · ¶¶Departments of Pathology and Laboratory Medicine and Genetics; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; · ‡‡Jim Ayers Institute for Precancer Detection and Diagnosis, Vanderbilt University School of Medicine, Nashville, Tennessee; · §§Houston Methodist Cancer Center, Houston, Texas; · ‖Pathology, Microbiology and Immunology; **Breast Cancer Research Program; Vanderbilt Ingram Cancer Center, Nashville, Tennessee; · Baylor Charles A. Sammons Cancer Center, Dallas, Texas; · Foundation Medicine, Cambridge, Massachusetts. · ¶Cancer Biology, ‖Pathology, Microbiology and Immunology; · Baylor Charles A. Sammons Cancer Center, Dallas, Texas; Texas Oncology, US Oncology, Dallas, Texas; · ‖‖The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; · ¶Cancer Biology, **Breast Cancer Research Program; Vanderbilt Ingram Cancer Center, Nashville, Tennessee; · From the Departments of ‡Medicine, ¶Cancer Biology, **Breast Cancer Research Program; Vanderbilt Ingram Cancer Center, Nashville, Tennessee; · Pubmed 25953087
  • Vanderbilt University, Department of Biomedical Engineering Station B, Box 1631, Nashville, Tennessee 37235, United States. · Vanderbilt University, Department of Cancer Biology, Breast Cancer Research Program, 2220 Pierce Avenue, Nashville, Tennessee 37232, United States. · Vanderbilt University, Department of Cancer Biology, Breast Cancer Research Program, 2220 Pierce Avenue, Nashville, Tennessee 37232, United StatescVanderbilt University, Department of Medicine, 2220 Pierce Avenue, Nashville, Tennessee 37232, United States. · Pubmed 25700233
  • Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee. · Department of Medical Oncology, Broad Institute of MIT at Harvard, Cambridge, Massachusetts. · Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 25480943
  • Department of Life Science, Hanyang University, Seoul, Korea. · Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · The Specific Organs Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang-si, Korea. · NOVA Cell Technology Inc., Pohang, Korea. · Department of Medicine, Vanderbilt University, Nashville, TN, USA. · 1] Department of Life Science, Hanyang University, Seoul, Korea [2] Natural Science Institute, Hanyang University, Seoul, Korea. · Pubmed 25342465
  • Department of Pharmacology and Toxicology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. · 1] Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA [2] Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Proteomics Laboratory, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · 1] Department of Breast Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA [2] Department of Systems Biology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. · Department of Systems Biology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. · 1] Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA [2] Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA [3] Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · 1] Department of Pharmacology and Toxicology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA [2] Comprehensive Breast Cancer Program, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Pubmed 25284585
2014
  • Ingrid A. Mayer, Vandana G. Abramson, Justin M. Balko, María Gabriela Kuba, Melinda E. Sanders, and Carlos L. Arteaga, Vanderbilt University, Nashville, TN · Steven J. Isakoff, Massachusetts General Hospital, Boston, MA · Andres Forero, University of Alabama, Birmingham, AL · Jeffrey T. Yap, Huntsman Cancer Institute, Salt Lake City, UT · Annick D. Van den Abbeele and Eric Winer, Dana-Farber Cancer Institute, Boston, MA · Yisheng Li, MD Anderson Cancer Center, Houston, TX · and Lewis C. Cantley, Weill Cornell Medical College, New York, NY. · Pubmed 24663045
  • Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Division de Investigación, Oncosalud, Lima, Peru. · Center for Molecular Diagnostics, Lima, Peru. · Department of Pathology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. · Department of Medicine, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University, Nashville, TN, USA. · Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. Electronic address: · Pubmed 25467032
  • Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee. · Takis Biotech, Rome, Italy. · IRCCS National Cancer Institute "G. Pascale," Naples, Italy. · Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. · Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee. · Pubmed 25100563
  • Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX. · Bioinformatics and Computational Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX. · Department of Pharmacology and Toxicology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH. Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN. · University of Georgia College of Pharmacy, Athens, GA. · Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX. · Veterinary Medicine and Surgery, The University of Texas, MD Anderson Cancer Center, Houston, TX. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN. Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN. · Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX. · Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX. Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX. · Pubmed 24979294
  • Department of Medicine, Department of Cancer Biology, and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Medicine, Department of Cancer Biology, and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA · Pubmed 24797823
  • Vanderbilt University, Department of Biomedical Engineering, VU Station B #351631, 2301 Vanderbilt Place, Nashville, Tennessee 37235bUniversity of Texas Health Science Center at Houston, Department of Nanomedicine and Biomedical Engineering, CABIR 3SCR.46. · Vanderbilt University, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232. · Vanderbilt University, Vanderbilt Center for Quantitative Sciences, Nashville, Tennessee 37232. · Vanderbilt University, Department of Biomedical Engineering, VU Station B #351631, 2301 Vanderbilt Place, Nashville, Tennessee 37235. · Pubmed 24496495
  • Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, 450 Brookline Ave. Boston, MA 02215. · Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215. · Foundation Medicine, One Kendall Sq. Cambridge, MA 02139. · Departments of Investigational Cancer Therapeutics, Surgical Oncology, The University of MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. · Departments of Systems Biology, and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. · Fundacion de Investigacion INCLIVA - Institute for Health Reseearch, Valencia, Spain. · Departments of Hematology-Oncology, Hospital Clinico Universitario de Valencia, Valencia, Spain. · Jefferson Breast Care Center, Kimmel Cancer Center, Thomas Jefferson University, 925 Chestnut St. Philadelphia, PA 19107. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2220 Pierce Ave, Nashville, TN 37232. · Teva Pharmaceuticals, 5 Basel St. Petach Tikva, Israel 49131. · Oncology Division, Tel Aviv Sourasky Medical Center , 6 Weizmann St. Tel Aviv 64239, Israel. · Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave. Boston MA 02215. · Breast Medical Oncology Program, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave. Boston MA 02215. · Section of Breast Medical Oncology, Yale School of Medicine, New Haven, South Frontage Rd and Park St. CN, 06510. · Pubmed 24398047
2013
  • Author's Affiliation: Departments of Medicine and Cancer Biology; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 24298065
2011
  • Breast Cancer Research Program, Vanderbilt Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, 1310 24th Avenue South, Nashville, TN 37212-2637, USA. · Pubmed 22124364
  • Departments of Medicine and Cancer Biology, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232-6307, USA. · Pubmed 21670086
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Division of Hematology/Oncology, VUMC, 2220 Pierce Avenue, 777 PRB, Nashville, TN 37232-6307, USA. · Pubmed 21457523
2015
  • Institute of Imaging Science, Vanderbilt University, 1161 21st Ave. South, MCN AA-1105, Nashville, TN, 37232-2675, USA. · Pubmed 25034624
2014
  • Department of Medicine, Vanderbilt University School of Medicine, 2220 Pierce Ave, 777 PRB, Nashville, TN, 37232, USA, · Pubmed 24722917
  • Departments of 1Medicine, 2Pathology, Microbiology & Immunology, 3Cancer Biology, and 4Biochemistry; 5Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee; Departments of 6Cell & Tissue Biology and 7Medicine, University of California, San Francisco, San Francisco, California; 8Foundation Medicine, Cambridge, Massachusetts; 9Oncosalud; and 10Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú · Pubmed 24356096
2013
  • Department of Medicine, Cancer Biology and Biostatistics, Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA. · Pubmed 23794708
  • Authors' Affiliations: Departments of Biomedical Engineering, Cancer Biology, Medicine, Vanderbilt University Institute of Imaging Science, and Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Nashville, Tennessee. · Pubmed 24130112
  • Authors' Affiliations: Departments of Medicine and Cancer Biology; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee; Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú; and Department of Pharmacology and Toxicology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. · Pubmed 23966295
  • Authors' Affiliations: Departments of Medicine and Cancer Biology, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center; Vanderbilt University, Nashville, Tennessee; Massachusetts General Hospital Cancer Center; and Department of Medicine, Harvard Medical School, Boston, Massachusetts. · Pubmed 23948973
  • Authors' Affiliations: Novartis Institutes for Biomedical Research, Cambridge, Massachusetts; Departments of Medicine and Cancer Biology; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee; MorphoSys AG, Martinsried, Germany; and Genomics Institute of the Novartis Research Foundation, San Diego, California. · Pubmed 23928993
  • Authors' Affiliations: Departments of Medicine and Cancer Biology; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center; Vanderbilt University, Nashville, Tennessee; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts; Integrated Oncology/LabCorp; and Monogram Biosciences/LabCorp, South San Francisco, California. · Pubmed 23918797
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 23391723
  • Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Pubmed 23224399
2012
  • Departments of Medicine and Cancer Biology, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37212, USA. · Pubmed 22471661
  • Vanderbilt University Medical Center, 2200 Pierce Ave, 777 PRB, Nashville, TN 37232-6307, USA. · Pubmed 22879364
  • Department of Medicine, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 22683778
  • Jim Ayers Institute for Precancer Detection and Diagnosis, Vanderbilt-Ingram Cancer Center, and Departments of ‡Biochemistry, §Pathology, and ¶Medicine, Vanderbilt University School of Medicine , Nashville, Tennessee 37232, United States. · Pubmed 22530795
  • Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Pubmed 22461506
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Pubmed 21368164
2011
  • Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Pubmed 22114931
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA. · Pubmed 22010023
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6307, USA. · Pubmed 21248299
  • Department of Cancer Biology, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee 37232-6307, USA. · Pubmed 22049316
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 21908557
  • Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. · Pubmed 21499296
  • Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Pubmed 21482676
  • Department of Medicine, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, and Vanderbilt University Institute of Imaging Sciences, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. · Pubmed 21385943
  • Department of Cancer Biology, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University, Nashville, Tennessee, USA. · Pubmed 21346144
  • Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee 37232, USA. · Pubmed 21324925
University of Texas Southwestern
2019
  • Departments of Medicine, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · UTSW Simmons Cancer Center, Dallas, TX, 75230, USA. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Departments of Biochemistry, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Vanderbilt Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, 37232-6307, TN, USA. · Departments of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Robert H Lurie Comprehensive Cancer Center, Chicago, 60611, IL, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, 02114, MA, USA. · Baylor University Medical Center, Texas Oncology, , US Oncology, Dallas, 75246, TX, USA. · Guardant Health, Redwood City, 94063, CA, USA. · Novartis Institutes for Biomedical Research, Cambridge, 02139, MA, USA. · Novartis Pharmaceuticals Corporation, East Hanover, 07936, NJ, USA. · Departments of Medicine, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · UTSW Simmons Cancer Center, Dallas, TX, 75230, USA. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, 37232-6307, TN, USA. · Pubmed 30914635
2018
  • Department of Gynaecology and Obstetrics, University Hospitals Leuven, KU Leuven, University of Leuven, Herestraat 49, 3000, Louvain, Belgium. · Department of Oncology, University Hospitals Leuven, KU Leuven, University of Leuven, 3000, Louvain, Belgium. · Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, University of Leuven, 3000, Louvain, Belgium. · Department of Radiology, KU Leuven, University Hospitals Leuven, 3000, Louvain, Belgium. · Department of Pathology, KU Leuven, University Hospitals Leuven, 3000, Louvain, Belgium. · Department of Human Genetics, University Hospitals Leuven, KU Leuven, University of Leuven, 3000, Louvain, Belgium. · Department of Gynaecology and Obstetrics, University Hospitals Leuven, KU Leuven, University of Leuven, Herestraat 49, 3000, Louvain, Belgium. · Department of Radiotherapy, University Hospitals Leuven, KU Leuven, University of Leuven, 3000, Louvain, Belgium. · Department of Imaging and Pathology, Laboratory of Translational Cell and Tissue Research, KU Leuven, University of Leuven, 3000, Louvain, Belgium. · University of Texas Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, TX, USA. · Pubmed 30187361
  • Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York, 14263, USA. · Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, New York, USA. · Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York, USA. · Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. · Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York, 14263, USA. · Pubmed 29921235
10 Other Locations Show
Yearly article counts 1514119151571610
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.